Induction of erythroid differentiation is associated with inhibition of glycolysis and a decrease in fructose 2,6-bisphosphate levels

International Journal of Oncology

Volumn 11, Issue 5, 1997, Pages 1135-1140

  Scher, Barbara M ^a,b   Chen, Jonathan Y H ^a   Fuksina, Inna ^a   Waxman, Samuel ^a   Scher, William ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Dimethyl sulfoxide; Erythroid differentiation; Erythroleukemia; Fructose 2,6 bisphosphate; Glucose metabolism; Hexamethylene bisacetamide; Lactate; Phosphofructokinase

Indexed keywords

6 PHOSPHOFRUCTOKINASE; DIMETHYL SULFOXIDE; FRUCTOSE 2,6 BISPHOSPHATE; FRUCTOSE 6 PHOSPHATE; GLUCOKINASE; GLYCOLYTIC ENZYME; HEXAMETHYLENEBISACETAMIDE; HEXOKINASE; LACTATE DEHYDROGENASE; LACTIC ACID; MANNOHEPTULOSE; PYRUVATE KINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; GLYCOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030809619     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.5.1135     Document Type: Article

References (10)

1. Hue L and Rousseau GG: Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. Adv Enzyme Regul 33: 97-110, 1993.
2. Rousseau GG and Hue L: Mammalian 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a bifunctional enzyme that controls glycolysis. Prog Nucl Acid Res Mol Biol 45: 99-127, 1993.
3. Darville MI, Antoine IV, Mertens-Strijthagen JR, Dupriez VJ and Rousseau GG: An E2F-dependent late-serum-response promoter in a gene that controls glycolysis. Oncogene 11: 1509-1517, 1995.
4. Pilkis SJ: 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. Ann Rev Biochem 64: 799-835, 1995.
5. Warburg O: On the origins of cancer cells. Science 124: 319-324, 1956.
6. Xu G, Livingston DM and Krek W: Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci USA 92: 1357-1361, 1995.
7. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E and Dyson NJ: Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548, 1996.
8. Field SJ, Tsai F-Y, Kuo F, Zubiaga AM, Kaelin Jr. WG, Livingston DM, Orkin SH and Greenberg ME: E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561, 1996.
9. Kiyokawa H, Richon VM, Rifkind RA and Marks PA: Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 14: 7195-7203, 1994.
10. Saito M, Helin K, Valentine MB, Griffith BB, Willman CL, Harlow E and Look AT: Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. Genomics 25: 130-138, 1995.